BPG is committed to discovery and dissemination of knowledge
Featured Articles
7/24/2026 6:21:59 AM | Browse: 3 | Download: 10
Publication Name World Journal of Clinical Oncology
Manuscript ID 119673
Country India
Received
2026-02-14 02:30
Peer-Review Started
2026-02-14 02:30
First Decision by Editorial Office Director
2026-02-25 07:58
Return for Revision
2026-02-25 07:58
Revised
2026-03-04 11:42
Publication Fee Transferred
Second Decision by Editor
2026-04-27 02:30
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-04-27 03:06
Articles in Press
2026-04-27 03:06
Edit the Manuscript by Language Editor
Typeset the Manuscript
2026-06-24 05:46
Publish the Manuscript Online
2026-07-24 06:11
ISSN 2218-4333 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Editorial
Article Title Prognostic significance of stem cell markers: In triple-negative breast cancers
Manuscript Source Invited Manuscript
All Author List Sunil V Jagtap and Shubham S Jagtap
Funding Agency and Grant Number
Corresponding Author Sunil V Jagtap, Professor, Department of Pathology, Krishna Vishwa Vidyapeeth, Krishna Institute of Medical Sciences e mail-research@kvv.edu.in, Malkapur, Karad 415110, Maharashtra, India. drsvjagtap@gmail.com
Key Words Triple-negative breast cancer; Cancer stem cell; Bio-markers; Prognostic Significance
Core Tip Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer characterized by absence of estrogen, progesteron and human epidermal growth factor receptor-2 expressions. TNBC exhibit cancer stem cell (CSC)-like properties at functional, molecular, and transcriptional levels. Stemness markers described across different histological subtypes include CD44, CD24, CD133, ALDH1 and ABCG2. These markers have prognostic and predictive value in TNBC, as their expression has been associated with increased tumor aggressiveness, chemoresistance, poor prognosis, lack of effective targeted therapies and unfavorable clinical outcomes. Recent studies on CSC markers in TNBC highlight their potential as new prognostic biomarkers and targeted therapies.
Publish Date 2026-07-24 06:11
Citation

Jagtap SV, Jagtap SS. Prognostic significance of stem cell markers: In triple-negative breast cancers. World J Clin Oncol 2026; 17(7): 119673

URL https://www.wjgnet.com/2218-4333/full/v17/i7/119673.htm
DOI https://doi.org/10.5306/wjco.v17.i7.119673
Full Article (PDF) WJCO-17-119673-with-cover.pdf
Manuscript File 119673_Auto_Edited_081929.docx
Answering Reviewers 119673-answering-reviewers.pdf
Audio Core Tip 119673-audio.mp4
Conflict-of-Interest Disclosure Form 119673-conflict-of-interest-statement.pdf
Copyright License Agreement 119673-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate 119673-non-native-speakers.pdf
Peer-review Report 119673-peer-reviews.pdf
Scientific Misconduct Check 119673-scientific-misconduct-check.png
Scientific Editor Work List 119673-scientific-editor-work-list.pdf
CrossCheck Report 119673-crosscheck-report.pdf